New Brunswick, N.J., February 12th, 2024 – Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
The audio webcast replay will be available approximately 48-hrs after the webcast.
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com